Skip to main content
NCBI home page
Focus: Journal of Life Long Learning in Psychiatry logoLink to Focus: Journal of Life Long Learning in Psychiatry
. 2019 Jan 7;17(1):50–51. doi: 10.1176/appi.focus.17101

Neuroscience-Informed Treatments

PMCID: PMC6493151  PMID: 31975961

This section contains a compilation of recent publications that have shaped the thinking in the field as well as classic works that remain important to the subject reviewed in this issue. This bibliography has been compiled by experts in the field and members of the editorial and advisory boards. Entries are listed chronologically and within topics and years by first author. Articles from the bibliography that are reprinted in this issue are in bold type.

2018

  1. Blumberger DM, Vila-Rodriguez F, Thorpe KE, et al. : Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial. Lancet 2018; 391:1683–1692 [DOI] [PubMed] [Google Scholar]
  2. Borrione L, Moffa AH, Martin D, et al. : Transcranial direct current stimulation in the acute depressive episode: a systematic review of current knowledge. J ECT 2018; 34:153–163 [DOI] [PubMed] [Google Scholar]
  3. Canuso CM, Singh JB, Fedgchin M, et al: Efficacy and safety of intranasal esketamine for the rapid reduction of symptoms of depression and suicidality in patients at imminent risk for suicide: results of a double-blind, randomized, placebo-controlled study. Am J Psychiatry 2018; 175:620–630 [DOI] [PubMed] [Google Scholar]
  4. Dougherty DD, Brennan BP, Stewart SE, et al. : Neuroscientifically informed formulation and treatment planning for patients with obsessive-compulsive disorder: a review. JAMA Psychiatry 2018; 75:1081–1087 [DOI] [PubMed] [Google Scholar]
  5. Gandal MJ, Haney JR, Parikshak NN, et al: Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap. Science 2018; 359:693–697 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Grazioli S, Mauri M, Crippa A, et al. : Light up ADHD: II. Neuropharmacological effects measured by near infrared spectroscopy: is there a biomarker? J Affect Disord 2018; 244:100–106 [DOI] [PubMed] [Google Scholar]
  7. Grunebaum MF, Galfalvy HC, Choo TH, et al. : Ketamine for rapid reduction of suicidal thoughts in major depression: a midazolam-controlled randomized clinical trial. Am J Psychiatry 2018; 175:327–335 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Loo CK, Husain MM, McDonald WM, et al. : International randomized-controlled trial of transcranial direct current stimulation in depression. Brain Stimul 2018; 11:125–133 [DOI] [PubMed] [Google Scholar]
  9. Martin DM, Moffa A, Nikolin S, et al. : Cognitive effects of transcranial direct current stimulation treatment in patients with major depressive disorder: an individual patient data meta-analysis of randomised, sham-controlled trials. Neurosci Biobehav Rev 2018; 90:137–145 [DOI] [PubMed] [Google Scholar]
  10. Marwood L, Wise T, Perkins AM, et al. : Meta-analyses of the neural mechanisms and predictors of response to psychotherapy in depression and anxiety. Neurosci Biobehav Rev 2018; 95:61–72 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. McClintock SM, Reti IM, Carpenter LL, et al. : Consensus recommendations for the clinical application of repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression. J Clin Psychiatry 2018; 79:35–48 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Moffa AH, Brunoni AR, Nikolin S, et al. : Transcranial direct current stimulation in psychiatric disorders: a comprehensive review. Psychiatr Clin North Am 2018; 41:447–463 [DOI] [PubMed] [Google Scholar]
  13. Nemeroff CB: Ketamine: quo vadis? Am J Psychiatry 2018; 175:297–299 [DOI] [PubMed] [Google Scholar]
  14. Pereira LP, Köhler CA, Stubbs B, et al. : Imaging genetics paradigms in depression research: systematic review and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 2018; 86:102–113 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ryan KM, McLoughlin DM: From molecules to mind: mechanisms of action of electroconvulsive therapy. Acta Psychiatr Scand 2018; 138:177–179 [DOI] [PubMed] [Google Scholar]
  16. Sanacora G, Katz R: Ketamine: a review for clinicians. Focus 2018; 16:243–250 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Sestan N, State MW: Lost in translation: traversing the complex path from genomics to therapeutics in autism spectrum disorder. Neuron 2018; 100:406–423 [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Short B, Fong J, Galvez V, et al. : Side-effects associated with ketamine use in depression: a systematic review. Lancet Psychiatry 2018; 5:65–78 [DOI] [PubMed] [Google Scholar]
  19. Stevens MC, Pearlson GD, Calhoun VD, et al. : Functional neuroimaging evidence for distinct neurobiological pathways in attention-deficit/hyperactivity disorder. Biol Psychiatry Cogn Neurosci Neuroimaging 2018; 3:675–685 [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Taylor SF, Ho SS, Abagis T, et al. : Changes in brain connectivity during a sham-controlled, transcranial magnetic stimulation trial for depression. J Affect Disord 2018; 232:143–151 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Tolmeijer E, Kumari V, Peters E, et al. : Using fMRI and machine learning to predict symptom improvement following cognitive behavioural therapy for psychosis. Neuroimage Clin 2018; 20:1053–1061 [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Volkow ND, Boyle M: Neuroscience of addiction: relevance to prevention and treatment. Am J Psychiatry 2018; 175:729–740 [DOI] [PubMed] [Google Scholar]

2017

  1. Antal A, Alekseichuk I, Bikson M, et al. : Low intensity transcranial electric stimulation: safety, ethical, legal regulatory and application guidelines. Clin Neurophysiol 2017; 128:1774–1809 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brunoni AR, Moffa AH, Sampaio-Junior B, et al. : Trial of electrical direct-current therapy versus escitalopram for depression. N Engl J Med 2017; 376:2523–2533 [DOI] [PubMed] [Google Scholar]
  3. Drysdale AT, Grosenick L, Downar J, et al. : Resting-state connectivity biomarkers define neurophysiological subtypes of depression. Nat Med 2017; 23:28–38 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ross DA, Arbuckle MR, Travis MJ, et al. : An integrated neuroscience perspective on formulation and treatment planning for posttraumatic stress disorder: an educational review. JAMA Psychiatry 2017; 74:407–415 [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Philip NS, Nelson BG, Frohlich F, et al. : Low-intensity transcranial current stimulation in psychiatry. Am J Psychiatry 2017; 174:628–639 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Sanacora G, Frye MA, McDonald W, et al. : A consensus statement on the use of ketamine in the treatment of mood disorders. JAMA Psychiatry 2017; 74:399–405 [DOI] [PubMed] [Google Scholar]

Further Reading

  1. Ballard ED, Ionescu DF, Vande Voort JL, et al. : Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety. J Psychiatr Res 2014; 58:161–166 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Berman RM, Cappiello A, Anand A, et al. : Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 2000; 47:351–354 [DOI] [PubMed] [Google Scholar]
  3. Bikson M, Grossman P, Thomas C, et al. : Safety of transcranial direct current stimulation: evidence based update 2016. Brain Stimul 2016; 9:641–661 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brunoni AR, Valiengo L, Baccaro A, et al. : The sertraline vs. electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial. JAMA Psychiatry 2013; 70:383–391 [DOI] [PubMed] [Google Scholar]
  5. Diazgranados N, Ibrahim L, Brutsche NE, et al. : A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry 2010; 67:793–802 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dichter GS, Felder JN, Petty C, et al. : The effects of psychotherapy on neural responses to rewards in major depression. Biol Psychiatry 2009; 66:886–897 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Haskett RF: Electroconvulsive therapy’s mechanism of action: neuroendocrine hypotheses. J ECT 2014; 30:107–110 [DOI] [PubMed] [Google Scholar]
  8. Insel TR, Quirion R: Psychiatry as a clinical neuroscience discipline. JAMA 2005; 294:2221–2224 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Jelovac A, Kolshus E, McLoughlin DM: Relapse following successful electroconvulsive therapy for major depression: a meta-analysis. Neuropsychopharmacology 2013; 38:2467–2474 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kellner CH, Greenberg RM, Murrough JW, et al. : ECT in treatment-resistant depression. Am J Psychiatry 2012; 169:1238–1244 [DOI] [PubMed] [Google Scholar]
  11. Kellner CH, Knapp RG, Petrides G, et al. : Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry 2006; 63:1337–1344 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kirov G, Ebmeier KP, Scott AI, et al. : Quick recovery of orientation after magnetic seizure therapy for major depressive disorder. Br J Psychiatry 2008; 193:152–155 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lebowitz MS, Ahn WK: Emphasizing malleability in the biology of depression: durable effects on perceived agency and prognostic pessimism. Behav Res Ther 2015; 71:125–130 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lisanby SH: Electroconvulsive therapy for depression. N Engl J Med 2007; 357:1939–1945 [DOI] [PubMed] [Google Scholar]
  15. Lisanby SH, Luber B, Schlaepfer TE, et al. : Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized within-subject comparison with electroconvulsive therapy. Neuropsychopharmacology 2003; 28:1852–1865 [DOI] [PubMed] [Google Scholar]
  16. Petrides G, Malur C, Braga RJ, et al: Electroconvulsive therapy augmentation in clozapine-resistant schizophrenia: a prospective, randomized study. Am J Psychiatry 2015; 172:52–58 [DOI] [PubMed] [Google Scholar]
  17. Semkovska M, McLoughlin DM: Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biol Psychiatry 2010; 68:568–577 [DOI] [PubMed] [Google Scholar]
  18. Skolnick P, Layer RT, Popik P, et al. : Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression. Pharmacopsychiatry 1996; 29:23–26 [DOI] [PubMed] [Google Scholar]
  19. Zanos P, Moaddel R, Morris PJ, et al. : NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature 2016; 533:481–486 [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Zarate CA, Jr, Singh JB, Carlson PJ, et al. : A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006; 63:856–864 [DOI] [PubMed] [Google Scholar]

Articles from Focus: Journal of Life Long Learning in Psychiatry are provided here courtesy of American Psychiatric Publishing

RESOURCES